Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,000.4
26.5 (0.89%)

 

  • STI Straits Times Index
    3,000.4
    26.5 (0.89%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,588.5
    18.6 (1.18%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,880.4
    784.6 (2.70%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,576.9
    68.3 (1.95%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,559.1
    150.9 (0.51%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,376.8
    17.6 (0.28%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,861.3M
  • Value: 1,448.8M
  • Rise: 169
  • Fall: 174
  • Unch: 431

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.042-0.022
FJ Benjamin0.046+0.026
Thomson Medical0.111-0.006
Jiutian Chemical0.084-0.003
CWX Global0.005-
Asian Pay Tv Tr0.105-0.004
Keppel Reit1.150-
Secura0.093+0.001
Yoma Strategic0.163+0.002
AusGroup0.026-0.001

World Indices

World Indices
Name Last Change
Nasdaq 13,358.8 -230.0
HSI 29,880.4 +784.6
HSCEI 11,666.2 +304.9
Jakarta 6,376.8 +17.6
Nikkei 225 29,559.1 +150.9
SSE Comp 3,576.9 +68.3
Shanghai A 3,749.3 +71.6
Shanghai B 249.2 +3.4
KOSPI 3,083.0 +39.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

METACRINE INC METACRINE
Updated on 02 Mar 2021 (End of trading day)
Last (USD): 9.190 Change: -0.070 High: 9.900 Remarks: -
Change (%): -0.76 Low: 9.110
Open 9.260 Yesterday's Close 9.26
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 39,280 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.11468 Trailing EPS (USD) e -1.11468 NAV (USD) b 3.7819
PE a - Trailing PE f - Price / NAV b 2.4300
Dividend (USD) d - Cash In Hand (USD) g 3.7864 Issued & Paid-up Shares c 25,956,300
Dividend Yield (%) d - Price / Cash In Hand g 2.427 Treasury Shares h -
Market Cap (M) 238.538 Enterprise Value (M) 140.529
Piotroski F Score 2 Exchange Code MTCR Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 42.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Nov 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 11 Sep 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference METACRINE INC NASDAQ 238.538 - - 2.4300 -
Industry Biotechnology NASDAQ 3,028.751 1438.131 - 7.5381 0.589
Local Peer AMGEN INC NASDAQ 130,350.871 17.945 17.945 13.8538 2.839
Local Peer GILEAD SCIENCES INC NASDAQ 79,177.736 643.747 643.721 4.3500 4.308
Local Peer ILLUMINA INC NASDAQ 64,343.359 98.084 98.084 13.7076 -
Local Peer MODERNA INC NASDAQ 58,690.234 - - 22.9136 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,127.118 20.330 20.330 6.3461 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 48,730.048 13.871 13.871 4.4198 -
Local Peer BIOGEN INC NASDAQ 41,107.870 10.275 10.275 3.8418 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 33,058.544 54.787 54.787 2.8374 -
Local Peer 10X GENOMICS INC NASDAQ 32,092.612 - - 43.4233 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 28,033.429 - - - -
Local Peer SEAGEN INC NASDAQ 27,846.718 45.377 45.377 7.9834 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 25,003.402 - - 22.9841 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), EXELIXIS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), ARVINAS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), SEER INC (NASDAQ), NANTKWEST INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ALKERMES PLC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ALLOVIR INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), BIOATLA INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PRECIGEN INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), UNIQURE N.V. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), NKARTA INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CYTOKINETICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ALECTOR INC (NASDAQ), PERSONALIS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), MIMEDX GROUP INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), EPIZYME INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), MANNKIND CORPORATION (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), CHIMERIX INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), RADIUS HEALTH INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CURIS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), VAXART INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), KADMON HLDGS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AKOUOS INC (NASDAQ), IMMATICS N V (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AGENUS INC (NASDAQ), AFFIMED N V (NASDAQ), ATRECA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ARDELYX INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALTIMMUNE INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), IVERIC BIO INC (NASDAQ), GERON CORP (NASDAQ), XBIOTECH INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ADICET BIO INC (NASDAQ), AVROBIO INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), SESEN BIO INC (NASDAQ), VERASTEM INC (NASDAQ), IMMUNOME INC (NASDAQ), XOMA CORP (NASDAQ), ATHERSYS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ONCORUS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), BIOVIE INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), TREVENA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), NEXTCURE INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), INMUNE BIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), IMV INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EVOGENE LTD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), EQUILLIUM INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), LONGEVERON INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), OTONOMY INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), INFLARX N V (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), COHBAR INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ADVAXIS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), PRECIPIO INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HISTOGEN INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), GEOVAX LABS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer CSL LTD ASX 121,488.204 38.736 31.922 11.4966 1.099
Global Peer WUXI BIO HKEx 431,119.360 375.023 299.407 28.8605 -
Global Peer BEIGENE HKEx 223,595.363 - - 7.4528 -
Global Peer SINO BIOPHARM HKEx 165,561.730 53.941 64.697 4.5936 0.606
Global Peer ZAI LAB-SB HKEx 102,108.072 - - - -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,292.690 17.347 17.347 3.6577 -
Global Peer JOINN HKEx 37,421.768 175.695 153.343 33.8817 0.166
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer GENSCRIPT BIO HKEx 29,006.444 - - 3.9672 -
Global Peer 3SBIO HKEx 20,348.800 18.430 13.552 1.7396 -
Other Global Peers ARCUS BIOSCIENCES INC (NYSE), NUVATION BIO INC (NYSE), MYOVANT SCIENCES LTD (NYSE), JW THERAP-B (HKEx), JACOBIO-B (HKEx), ALPHAMAB-B (HKEx), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), JHBP-B (HKEx), ASCENTAGE-B (HKEx), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), KINTOR PHARMA-B (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), OPTHEA LIMITED (ASX), LEE'S PHARM (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), NANOVIRICIDES INC (NYSE American), IMUGENE LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ANTEOTECH LIMITED (ASX), BIONOMICS LTD (ASX), BIOMX INC (NYSE American), NEXT SCIENCE LTD (ASX), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), IBIO INC (NYSE American), ENZO BIOCHEM INC (NYSE), KAZIA THERAPEUTICS LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), CHIMERIC THERAPEUTICS LTD (ASX), UNI-BIO GROUP (HKEx), LEAF RESOURCES LTD (ASX), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), MEMPHASYS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), BIOTRON (ASX), PATRYS LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), Suntar Eco-City (SGX), ADALTA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.330
+3.72 %
10 Days --1.570
-14.59 %
20 Days --0.690
-6.98 %
Medium Term Return 3 Months -+1.200
+15.02 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 7.640 - 16.190 Change From 1 Year Low +1.550 % Change From 1 Year Low (%) +20.29
Change From 1 Year High -7.000 % Change From 1 Year High (%) -43.24
2 Years Range 7.640 - 16.190 Change From 2 Years Low +1.550 % Change From 2 Years Low (%) +20.29
Change From 2 Years High -7.000 % Change From 2 Years High (%) -43.24
5 Years Range 7.640 - 16.190 Change From 5 Years Low +1.550 % Change From 5 Years Low (%) +20.29
Change From 5 Years High -7.000 % Change From 5 Years High (%) -43.24
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Metacrine, Inc. is a clinical-stage biopharmaceutical company that engages in the discovery and development of differentiated therapies for patients with liver and gastrointestinal diseases. Its farnesoid X receptor, or FXR, is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
02 Mar 2021 9.260 9.900 9.110 9.190 39,280 -
01 Mar 2021 8.590 9.750 8.590 9.260 42,943 -
26 Feb 2021 8.400 8.960 8.350 8.500 26,555 -
25 Feb 2021 8.573 8.785 8.380 8.440 18,755 -
24 Feb 2021 8.690 9.000 8.690 8.860 9,056 -
23 Feb 2021 8.730 9.040 8.520 8.600 40,715 -
22 Feb 2021 9.350 9.456 8.965 9.030 20,066 -
19 Feb 2021 9.050 9.400 9.050 9.350 18,634 -
18 Feb 2021 10.820 10.820 9.170 9.190 47,227 -
17 Feb 2021 10.840 10.950 10.528 10.760 37,531 -
16 Feb 2021 10.800 11.000 10.600 11.000 64,520 -
12 Feb 2021 10.360 10.860 10.020 10.820 74,977 -
11 Feb 2021 10.180 10.380 9.990 10.220 26,356 -
10 Feb 2021 10.410 10.500 10.000 10.090 75,353 -
09 Feb 2021 9.960 10.350 9.960 10.330 77,216 -
08 Feb 2021 10.000 10.190 9.830 9.950 48,443 -
05 Feb 2021 9.790 9.790 9.460 9.640 71,465 -
04 Feb 2021 9.880 10.000 9.700 9.730 88,609 -
03 Feb 2021 10.190 10.190 9.500 9.880 76,569 -
02 Feb 2021 9.940 10.400 9.940 10.290 29,303 -
01 Feb 2021 9.890 10.500 9.750 9.890 64,768 -
29 Jan 2021 9.580 9.790 9.461 9.730 127,475 -
Summary
Current 2 Weeks
(17 Feb 2021 to 02 Mar 2021)		 10.840 10.950 8.350 9.190 300,762 -
Previous 2 Weeks
(02 Feb 2021 to 16 Feb 2021)		 9.940 10.950 8.350 11.000 632,811 -
4 Weeks from
(04 Jan 2021 to 01 Feb 2021)		 7.940 10.950 7.860 9.890 907,251 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.